Literature DB >> 26445615

Identification of novel microtubule-binding proteins by taxol-mediated microtubule stabilization and mass spectrometry analysis.

Xianfei He1, Zhu Liu2, Qianqian He1, Juan Qin1, Ningning Liu1, Linlin Zhang1, Dengwen Li1, Jun Zhou1, Wenqing Shui3, Min Liu2.   

Abstract

Microtubule-binding proteins (MBPs) are structurally and functionally diverse regulators of microtubule-mediated cellular processes. Alteration of MBPs has been implicated in the pathogenesis of human diseases, including cancer. MBPs can stabilize or destabilize microtubules or move along microtubules to transport various cargoes. In addition, MBPs can control microtubule dynamics through direct interaction with microtubules or coordination with other proteins. To better understand microtubule structure and function, it is necessary to identify additional MBPs. In this study, we isolated microtubules and MBPs from mammalian cells by a taxol-based method and then profiled a panel of MBPs by mass spectrometry. We discovered a number of previously uncharacterized MBPs, including several membrane-associated proteins and proteins involved in post-translational modifications, in addition to several structural components. These results support the notion that microtubules have a wide range of functions and may undergo more exquisite regulation than previously recognized.

Entities:  

Keywords:  Mass spectrometry; microtubule; microtubule-binding protein; taxol; tubulin

Year:  2015        PMID: 26445615      PMCID: PMC4567012          DOI: 10.1111/1759-7714.12284

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


Introduction

Microtubules are long hollow polymers composed of α- and β-tubulin heterodimers. As one of the major components of the cytoskeleton present in nearly all eukaryotic cells, microtubules play important roles in many cellular processes, such as intracellular transport, cell motility, and cell division. Microtubules are highly dynamic, and the dynamic property is crucial for microtubules to carry out most of their cellular functions.1,2 Microtubule dynamics also render microtubules having different behaviors in different cell types or different cell cycle phases. In some tissue-specific cells, microtubules are stable and form highly specialized structures, such as cilia and axon. Microtubules are known to undergo post-translational modifications (PTMs), such as acetylation and detyrosination, which play a critical role in the modulation of microtubule dynamics and functions.3–5 In addition to PTMs, microtubule-binding proteins (MBPs) are essential for the regulation of microtubule dynamics.6–8 Defects in MBPs can result in disorganized assembly or deregulated dynamics of microtubules, leading to cell dysfunction and various diseases.9–13 Microtubule-dependent motors, such as kinesin and dynein, are highly conserved MBPs that generate force and movement on microtubules by adenosine triphosphate hydrolysis.2,14 Microtubule plus end-tracking proteins (+TIPs), such as end-binding protein 1 (EB1) and cytoplasmic linker protein of 170 kDa (CLIP-170), are another group of MBPs that are critically involved in the regulation of microtubule dynamics.15 In addition, a number of enzymes, such as the deubiquitinase cylindromatosis (CYLD), histone deacetylase 6 (HDAC6), and the E3 ubiquitin ligase parkin, can associate with microtubules and regulate microtubule dynamics.16–22 To better understand microtubule structure and function, we sought to discover novel MBPs by taxol-based microtubule separation followed by mass spectrometry.

Materials and methods

Materials

Taxol was purchased from Sigma-Aldrich (St Louis, MO, USA), and guanosine-5′-triphosphate from Millipore (Bedford, MA, USA). Antibodies against α-tubulin were obtained from Sigma-Aldrich, EB1 from BD Transduction Laboratories (San José, CA, USA), and CYLD, CLIP-170, and HDAC6 from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Centrosomal protein of 70 kDa (Cep70) antibody was generated as described previously.23 Horseradish peroxidase-conjugated secondary antibodies were obtained from Amersham Biosciences (Chandler, AZ, USA). Microtubule-associated protein (MAP)-free tubulin was obtained from the Cytoskeleton Inc. (Denver, CO, USA).

Cell culture

HeLa cells were obtained from the American Type Cell Collection (Manassas, VA, USA) and grown at 37°C in Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum in humidified air with 5% CO2.

Isolation of microtubules and mass spectrometry

Microtubules and MBPs were purified based on taxol-induced microtubule stabilization and cold-induced microtubule depolymerization. Proteins were subjected to standard in-gel tryptic digestion and analyzed by mass spectrometry, as previously described.24

Western blot analysis

Proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride membranes (Millipore). The membranes were blocked with 5% fat-free milk in Tris-buffered saline containing 0.1% Tween 20, and probed with primary antibodies, followed by horseradish peroxidase-conjugated secondary antibodies, as previously described.25 The target proteins were visualized with enhanced chemiluminescence detection reagent following the manufacturer’s instructions (Pierce Biotechnology, Rockford, IL, USA).

Results

To obtain MBP-containing fractions, we lysed HeLa cells and then separated cytosolic components from membranes and nuclei by centrifugation. Microtubules and MBPs were then purified based on taxol-induced microtubule stabilization and cold-induced microtubule depolymerization (Fig 1a). After two cycles of polymerization and depolymerization followed by ultracentrifugation, we obtained the PIII and SIII fractions, containing microtubules and MBPs, respectively (Fig 1a). Coomassie blue and silver staining showed the high purity of isolated microtubules (Fig 1b). In addition, silver staining revealed that the SIII fraction obtained from a salt wash of microtubule pellets contained a much lower amount of proteins compared with the SII fraction (Fig 1c).
Figure 1

Isolation of microtubules and microtubule-binding proteins (MBPs) from HeLa cells. (a) Schematic diagram of taxol-based microtubule purification from HeLa cells. (b) Coomassie blue staining of microtubule-associated protein (MAP)-free tubulin and PIII purified from HeLa cells. (c) Silver staining of MAP-free tubulin, PIII, SII, and SIII. GTP, guanosine-5′-triphosphate; S, supernatant; P, pellet.

Isolation of microtubules and microtubule-binding proteins (MBPs) from HeLa cells. (a) Schematic diagram of taxol-based microtubule purification from HeLa cells. (b) Coomassie blue staining of microtubule-associated protein (MAP)-free tubulin and PIII purified from HeLa cells. (c) Silver staining of MAP-free tubulin, PIII, SII, and SIII. GTP, guanosine-5′-triphosphate; S, supernatant; P, pellet. To verify the specificity of the isolated MBPs, we examined several known MBPs in the SII and SIII fractions. In agreement with previous findings that CLIP-170 and EB1 bound tightly to microtubules, Western blot analysis showed that the +TIPs proteins CLIP-170 and EB1 were present in both SII and SIII fractions (Fig 2).15 By contrast, Cep70, CYLD, and HDAC6 were entirely or primarily present in the SII fraction (Fig 2), consistent with their relatively low binding affinity to microtubules.23,26,27 Thus, the MBPs in the SIII fraction of HeLa cells were highly specific.
Figure 2

Western blot analysis of SII and SIII fractions with antibodies against several known microtubule-binding proteins (MBPs). Note that cytoplasmic linker protein of 170 kDa (CLIP-170) and end-binding protein 1 (EB1) exist in large amounts in both SII and SIII fractions, whereas deubiquitinase cylindromatosis (CYLD), histone deacetylase 6 (HDAC6), and centrosomal protein of 70 kDa (Cep70) are entirely or primarily in the SII fraction.

Western blot analysis of SII and SIII fractions with antibodies against several known microtubule-binding proteins (MBPs). Note that cytoplasmic linker protein of 170 kDa (CLIP-170) and end-binding protein 1 (EB1) exist in large amounts in both SII and SIII fractions, whereas deubiquitinase cylindromatosis (CYLD), histone deacetylase 6 (HDAC6), and centrosomal protein of 70 kDa (Cep70) are entirely or primarily in the SII fraction. To profile individual MBPs in the SIII fraction, we loaded the acetone-precipitated proteins to the SDS-PAGE gel and concentrated them into a single band. This band was subjected to in-gel digestion and resulting peptides were analyzed by nano-liquid chromatography-mass spectrometry/liquid chromatography-tandem mass spectrometry for protein identification (Fig 3a). A representative total ion chromatogram for the MBP-derived peptide analysis shown in Figure 3b indicates the complexity of protein composition in the SIII fraction. A number of novel MBPs identified in our study are listed in Table 1. Interestingly, these candidate MBPs include several membrane-associated proteins, such as importin 5, clathrin, and vinculin. We also identified a few proteins involved in PTM regulation, such as ubiquitin-like modifier activating enzyme 1 and isoform 1 of protein diaphanous homolog 1. These results support the notion that microtubules have a wide range of functions and may undergo more exquisite regulation than previously recognized.
Figure 3

Identification of novel microtubule-binding proteins (MBPs) through mass spectrometry analysis. (a) Schematic diagram for the preparation of MBP peptides by acetone precipitation and in-gel digestion. (b) The total ion chromatogram for nano liquid chromatography-mass spectrometry/liquid chromatography-tandem mass spectrometry (nanoLC-MS/MS) analysis of MBP peptides. MS, mass spectrum; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Table 1

List of MBPs identified by high-resolution mass spectrometry

AccessionDescriptionM.W. (kDa)Pi (pH)Biological process
IPI00792677.1cDNA FLJ60097 highly similar to tubulin alpha ubiquitous chain464.78Microtubule-based process
IPI00009342.1Ras GTPase activating like protein IQGAP11896.04Cell signaling
IPI00021439.1Actin cytoplasmic 1425.14Cytoskeleton organization
IPI00645452.1Tubulin beta484.50Microtubule-based process
IPI00179330.6Ubiquitin 40S ribosomal protein S27a1810.02Cell signaling
IPI00553169.5Uncharacterized protein2465.56Unknown
IPI00645078.1Ubiquitin like modifier activating enzyme 11185.37Protein modification
IPI00414676.6HSP 90 beta834.77Stress and immune response
IPI00382470.3Isoform 2 of HSP 90 alpha984.88Stress and immune response
IPI00003865.1Isoform 1 of heat shock cognate 71 kDa protein715.20Stress response
IPI00000877.1Hypoxia up-regulated protein 11114.97Stress response
IPI00002966.2Heat shock 70 kDa protein 4944.91Stress response
IPI00291175.7Isoform 1 of vinculin1175.72Cell junction/cell adhesion
IPI00793443.2Isoform 1 of importin 51244.64Protein transport
IPI00914026.1Dynactin subunit 1 isoform 41275.16Nuclear migration
IPI00022434.4Uncharacterized protein726.30Unknown
IPI00024067.4Isoform 1 of clathrin heavy chain 11915.35Protein transport
IPI00028275.2Isoform 1 of cytoskeleton associated protein 52257.67Microtubule-based process
IPI00037283.3Isoform 5 of dynamin 1 like protein796.48Membrane fission, endocytosis
IPI00643920.3cDNA FLJ54957 highly similar to Transketolase687.47Unknown
IPI00020035.4Protein NipSnap homolog 3B289.57Unknown
IPI00100160.3Isoform 1 of cullin associated NEDD8 dissociated protein 11365.41Cell differentiation
IPI00852685.1Isoform 1 of protein diaphanous homolog 11415.14Microtubule-based process
IPI00979442.1cDNA FLJ46846 fis clone UTERU30046351815.71Unknown
IPI00880007.2Microtubule associated protein2455.83Microtubule-based process
IPI00022058.3Isoform 1 of ArfGAP with SH3 domain ANK repeat and PH domain containing protein 21126.22Cilium morphogenesis
IPI00216694.3Isoform 3 of plastin715.26Bone development
IPI00465128.4Isoform 1 of large proline rich protein BAG61195.28Cell differentiation and tissue development

ANK, ankylin; BAG6, BCL2-associated athanogene 6; cDNA, complementary DNA; HSP, heat shock protein; MBPs, microtubule-binding proteins.

Identification of novel microtubule-binding proteins (MBPs) through mass spectrometry analysis. (a) Schematic diagram for the preparation of MBP peptides by acetone precipitation and in-gel digestion. (b) The total ion chromatogram for nano liquid chromatography-mass spectrometry/liquid chromatography-tandem mass spectrometry (nanoLC-MS/MS) analysis of MBP peptides. MS, mass spectrum; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis. List of MBPs identified by high-resolution mass spectrometry ANK, ankylin; BAG6, BCL2-associated athanogene 6; cDNA, complementary DNA; HSP, heat shock protein; MBPs, microtubule-binding proteins.

Discussion

Diverse microtubule-based cellular processes not only rely on microtubules per se but also MBPs. MBPs have also been demonstrated to regulate the binding of microtubule-targeting drugs to microtubules, thereby modulating cancer cell sensitivity to these drugs.21,28–31 Therefore, the identification of MBPs is of great significance in order to understand microtubule structure and function, as well as the mechanisms underlying cancer chemotherapeutic sensitivity. For example, CYLD is a recently identified MBP that regulates microtubule dynamics and participates in cell migration, cell division, angiogenesis, and ciliogenesis.16,17,19,27,32 CYLD has also been shown to stimulate noscapine activity in acute lymphoblastic leukemia via a microtubule-dependent mechanism.31 In addition, parkin, CLIP-170, and EB1 have been reported to bind microtubules and promote the sensitivity of breast cancer cells to taxol.21,29,30 MBPs are known to interact with microtubule via specific domains or motifs. For example, the cytoskeleton-associated protein-glycine-rich domain mediates the interaction of CYLD with microtubules, whereas calponin homology domain mediates the interaction of EB1 with microtubules.16,33,34 In this study, using a combination of taxol-based microtubule isolation and mass spectrometry, we have identified a list of proteins that may potentially associate with microtubules. It is important to validate these MBPs through biochemical analysis and immunofluorescence microscopy. In the future, examination of the profiles of these MBPs in different cell types and cell cycle stages and the mechanistic details for how these proteins interact with microtubules is necessary. Investigation of these proteins using their known structural and functional information may provide useful knowledge for the diverse roles of microtubules. In addition, MBPs are known to act in concert to regulate microtubule structure and function.18,35 Therefore, it will be important to analyze whether the novel MBPs coordinate with known MBPs to carry out their functions.
  35 in total

1.  Mdp3 is a novel microtubule-binding protein that regulates microtubule assembly and stability.

Authors:  Xiaoou Sun; Xingjuan Shi; Min Liu; Dengwen Li; Linlin Zhang; Xinqi Liu; Jun Zhou
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 2.  Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions.

Authors:  Carsten Janke; Jeannette Chloë Bulinski
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-16       Impact factor: 94.444

Review 3.  Cell and molecular biology of microtubule plus end tracking proteins: end binding proteins and their partners.

Authors:  Susana Montenegro Gouveia; Anna Akhmanova
Journal:  Int Rev Cell Mol Biol       Date:  2010       Impact factor: 6.813

4.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

5.  CYLD coordinates with EB1 to regulate microtubule dynamics and cell migration.

Authors:  Dengwen Li; Jinmin Gao; Yunfan Yang; Lei Sun; Shaojun Suo; Youguang Luo; Wenqing Shui; Jun Zhou; Min Liu
Journal:  Cell Cycle       Date:  2014-01-21       Impact factor: 4.534

6.  CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6.

Authors:  Yunfan Yang; Jie Ran; Min Liu; Dengwen Li; Yuanyuan Li; Xingjuan Shi; Dan Meng; Junmin Pan; Guangshuo Ou; Ritu Aneja; Shao-Cong Sun; Jun Zhou
Journal:  Cell Res       Date:  2014-10-24       Impact factor: 25.617

7.  Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.

Authors:  Roman Rouzier; Radhika Rajan; Peter Wagner; Kenneth R Hess; David L Gold; James Stec; Mark Ayers; Jeffrey S Ross; Peter Zhang; Thomas A Buchholz; Henry Kuerer; Marjorie Green; Banu Arun; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-24       Impact factor: 11.205

8.  CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation.

Authors:  Yunfan Yang; Min Liu; Dengwen Li; Jie Ran; Jinmin Gao; Shaojun Suo; Shao-Cong Sun; Jun Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

9.  Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells.

Authors:  Dengwen Li; Xiaodong Sun; Linlin Zhang; Bing Yan; Songbo Xie; Ruming Liu; Min Liu; Jun Zhou
Journal:  Protein Cell       Date:  2014-01-29       Impact factor: 14.870

10.  End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability.

Authors:  Youguang Luo; Dengwen Li; Jie Ran; Bing Yan; Jie Chen; Xin Dong; Zhu Liu; Ruming Liu; Jun Zhou; Min Liu
Journal:  Protein Cell       Date:  2014-04-19       Impact factor: 14.870

View more
  9 in total

Review 1.  Molecular mechanisms underlying stress response and adaptation.

Authors:  Shuang Sun; Jun Zhou
Journal:  Thorac Cancer       Date:  2017-12-26       Impact factor: 3.500

2.  EB1 phosphorylation mediates the functions of ASK1 in pancreatic cancer development.

Authors:  Siqi Gao; Youguang Luo; Xiaofan Wu; Yuanyuan Li; Yunqiang Zhou; Rui Lyu; Min Liu; Dengwen Li; Jun Zhou
Journal:  Oncotarget       Date:  2017-09-18

3.  Exopolysaccharides from a Codonopsis pilosula endophyte activate macrophages and inhibit cancer cell proliferation and migration.

Authors:  Min Chen; Yuanyuan Li; Zhu Liu; Yajun Qu; Huajie Zhang; Dengwen Li; Jun Zhou; Songbo Xie; Min Liu
Journal:  Thorac Cancer       Date:  2018-03-25       Impact factor: 3.500

Review 4.  Non-canonical functions of the mitotic kinesin Eg5.

Authors:  Min Liu; Jie Ran; Jun Zhou
Journal:  Thorac Cancer       Date:  2018-06-21       Impact factor: 3.500

Review 5.  Alteration of cell junctions during viral infection.

Authors:  Dan Dong; Wei Xie; Min Liu
Journal:  Thorac Cancer       Date:  2020-02-04       Impact factor: 3.500

Review 6.  Application of electrochemical biosensors in tumor cell detection.

Authors:  Zhenhua Zhang; Qingchao Li; Xin Du; Min Liu
Journal:  Thorac Cancer       Date:  2020-02-26       Impact factor: 3.500

7.  KIAA0100 Modulates Cancer Cell Aggression Behavior of MDA-MB-231 through Microtubule and Heat Shock Proteins.

Authors:  Zhenyu Zhong; Vaishali Pannu; Matthew Rosenow; Adam Stark; David Spetzler
Journal:  Cancers (Basel)       Date:  2018-06-04       Impact factor: 6.639

8.  Effects of FSTL1 on the proliferation and motility of breast cancer cells and vascular endothelial cells.

Authors:  Yang Yang; Tianhao Mu; Te Li; Songbo Xie; Jun Zhou; Min Liu; Dengwen Li
Journal:  Thorac Cancer       Date:  2017-08-30       Impact factor: 3.500

Review 9.  Environmental pollutants damage airway epithelial cell cilia: Implications for the prevention of obstructive lung diseases.

Authors:  Yu Cao; Miao Chen; Dan Dong; Songbo Xie; Min Liu
Journal:  Thorac Cancer       Date:  2020-01-24       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.